Jan HM 🪷
@jhxii_13
Assabentant-me de tot, sobretot del drama | 👨🏼🔬PhD fellow @Casanova_Acebes | 🔎 immune clones 🧫🌳 in breast cancer metastasis @CNIOStopCancer ~🇪🇸🇩🇪🇪🇺
ID: 2158920528
https://casanovaacebeslab.com/members/jan-hochstadt 27-10-2013 13:53:08
6,6K Tweet
866 Followers
4,4K Following
How the same cancer driver mutations can manifest differently across the lifespan cell.com/cancer-cell/fu… Cancer Cell Razelle Kurzrock, MD Vivek Subbiah, MD
What is the impact of immune checkpoint inhibitors in the outcome of patients with early breast cancer? Check out this huge work led by Guillermo Villacampa and Tomás Pascual Treatment tailoring is paramount to improve patient care! ESMO - Eur. Oncology OncoAlert Vall d’Hebron Institute of Oncology (VHIO) ASCO
Super happy to share that our paper is published in nature today! We've discovered how the breast is protected against tumor initiation—though it comes at a cost. 📰Read all about it here: bit.ly/3MSxoa1 🏥CCB_VIB_KUL Department of Oncology - KU Leuven The Netherlands Cancer Institute Van Rheenen Lab Benjamin Simons
Just out Science Magazine The aged immune system promotes cancer progression, implicating interleukin-1 ⍺ as a key mediator, as seen in old mice model and patients, with potential path for therapy science.org/doi/10.1126/sc… Miriam Merad, MD, PhD Lipschultz Precision Immunology Institute Icahn School of Medicine at Mount Sinai
Yet another study showing how the bone marrow contributes to the heterogeneity of myeloid cells in the periphery i.e. skin. Congratulations Anna Appios Clare Bennett and co-authors for this beautiful work! Bravo 👏 science.org/doi/10.1126/sc…
Terrific discussion by MarleenKokLab about OS benefit in TNBC achieved in the KEYNOTE 522 trial 🔥We cure more TNBC patients❗️ How to build on this wonderful achievement? Which is the knowledge gap? ESMO - Eur. Oncology Rebecca Dent OncoAlert #ESMO24
REVIEW Nature Immunology Belinda Parker The complexity of immune evasion mechanisms throughout the metastatic cascade nature.com/articles/s4159…